Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression

Completed · Phase 3 · Has a placebo group

Conditions studied: Depression

In brief

The purposes of this study are to determine: * The safety of duloxetine and any side effects that might be associated with it. * How duloxetine compares to escitalopram and placebo (an inactive ingredient)

Key facts

Study ID

NCT00073411

Run by

Eli Lilly and Company

People needed

675

Starts

2003-11-01

Expected to finish

2005-05-01

Last updated by the study team

2007-07-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be at least 18 of age
• Must meet the criteria for major depressive disorder
• You must be able to visit the doctor's office about once a week for 2 to 3 months. After that, you will need to visit the doctor's office once a month for about 6 months
• You must be able to take the study drug as prescribed (6 capsules per day taken once-daily)

You may not qualify if…

• You are a woman and are pregnant or breastfeeding.
• You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.
• You have a history of alcohol or drug dependence within the past 6 months

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.